The use of the commercial MLPA kit (P-050 MRC-Holland) to define CYP21A2 locus rearrangements is particularly helpful for the identification of a significant portion of CAH-X patients, in particular those that carry the CH-1 chimeric gene. The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.